NEW YORK – Race-based survival disparities in patients diagnosed with acute myeloid leukemia have widened over time, even as survival rates overall have trended toward improvement. This is one of the troubling findings of a study presented Sunday during the American Society of Hematology's annual meeting.
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try Premium Access now.
You may already have institutional access!
Check if I qualify.
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.